Nuzenio

Rocket Pharmaceuticals Announces

Rocket Pharmaceuticals Announces news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Rocket Pharmaceuticals Reports Positive Safety Update for RP-A501 Under Modified Phase 2 Protocol in Danon Disease - BioPharm InternationalBioPharm International · Mon, 03 Aug 2026 17:07:07 GMTTwist Bioscience Sees AI Drug Discovery Pipeline Expand - BenzingaBenzinga · Mon, 03 Aug 2026 16:13:44 GMTRocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease - Business WireBusiness Wire · Mon, 03 Aug 2026 11:00:00 GMTRocket Pharmaceuticals Provides Positive Clinical Safety Update from Initial Three Patients Treated with Rp-A501 Under Modified Phase 2 Protocol for Danon Disease - marketscreener.commarketscreener.com · Mon, 03 Aug 2026 11:00:00 GMTVanguard Portfolio Management (RCKT) reports 5.35% Rocket Pharmaceuticals ownership - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMTMeitheal Pharmaceuticals Announces FDA Approval of Garzulys™ (insulin aspart-fsan) Injection - BioSpaceBioSpace · Fri, 31 Jul 2026 02:43:16 GMT

Timeline

Mon, 03 Aug 2026 17:07:07 GMTRocket Pharmaceuticals Reports Positive Safety Update for RP-A501 Under Modified Phase 2 Protocol in Danon Disease - BioPharm International
Mon, 03 Aug 2026 16:13:44 GMTTwist Bioscience Sees AI Drug Discovery Pipeline Expand - Benzinga
Mon, 03 Aug 2026 11:00:00 GMTRocket Pharmaceuticals Announces Positive Clinical Safety Update from Initial Three Patients Treated with RP-A501 Under Modified Phase 2 Protocol for Danon Disease - Business Wire
Mon, 03 Aug 2026 11:00:00 GMTRocket Pharmaceuticals Provides Positive Clinical Safety Update from Initial Three Patients Treated with Rp-A501 Under Modified Phase 2 Protocol for Danon Disease - marketscreener.com
Fri, 31 Jul 2026 07:00:00 GMTVanguard Portfolio Management (RCKT) reports 5.35% Rocket Pharmaceuticals ownership - Stock Titan
Fri, 31 Jul 2026 02:43:16 GMTMeitheal Pharmaceuticals Announces FDA Approval of Garzulys™ (insulin aspart-fsan) Injection - BioSpace

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Rocket Pharmaceuticals Announces.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.